에이비엘바이오
40,850KRWMarket close of 10/27 (Tue)
Up +0.12%+50KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)41,800KRWUp +2.33%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 41,000
- High
- 42,600
- Low
- 40,450
- Day range
- Day range low 40,450 high 42,600, open 41,000, close 40,850, previous close 40,800
- Volume
- 25×10K shares
- 10.2B KRW 0.64× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
0%1-year close range 40,550 to 245,500 won, 0% up from the low
0% of the way up from the lowest close in 1 year (252 sessions) · -83.4% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27Points to check
- Earningsto check-86.1B KRWOperating income over the last four quarters -86.1B KRW (loss)
- Foreign & institutionalto check-3.7B KRW5 sessions: foreign -3.3B KRW · institutional -0.4B KRWLast 5 sessions: foreigners -3.3B KRW · institutions -400.00 million KRW
- Recent filingsnot verifiedCould not read filing data, so not verified
The other 2 are within the usual range
- Daily move+0.12%usual range
- Trading value0.6×usual range
See the full check report
Same sector · 제약
Down -2.22%· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +0.6% | Down -5.37% | 124.5B KRW |
| 셀트리온 | Close over the last 20 sessions +6.3% | Down -0.74% | 82.4B KRW |
| 지투지바이오 | Close over the last 20 sessions +22.2% | Down -13.38% | 46.9B KRW |
| 한미약품 | Close over the last 20 sessions -32.6% | Down -0.57% | 25.5B KRW |
| 에스티팜 | Close over the last 20 sessions -11.9% | Down -9.15% | 21.4B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 19 days
- Next data 10/29 (Thu) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.